A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Napoleone Ferrara, Karen Carver-Moore, Helen Chen et al. · Nature · 1996 · 3.7K citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations

Medicine, Cancer Biology, Oncology +14

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

Lars Holmgren, Michael S. O’Reilly, Judah Folkman · Nature Medicine · 1995 · 1.9K citations

Medicine, Cancer Biology, Oncology +14

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

Noel Weidner, J Folkman, F. Pozza et al. · JNCI Journal of the National Cancer Institute · 1992 · 1.8K citations

Medicine, Cancer Biology, Oncology +14

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Leonard G. Presta, H Chen, Shane J. O'Connor et al. · PubMed · 1997 · 1.6K citations

Medicine, Oncology, Ophthalmology +17